26 filings
Page 2 of 2
6-K
wq3ttp2hi2jr
29 Apr 19
Current report (foreign)
5:23pm
6-K
txat77evgx 1lg2
26 Apr 19
Current report (foreign)
1:32pm
6-K
egn7 k9zyv5yzg3u
23 Apr 19
Akari Reports Fourth Quarter and Full Year 2018 Financial Results and Business Highlights
4:20pm
6-K
5d8k6ka5hp60469c
23 Apr 19
Akari Therapeutics Announces Positive Initial Phase II Clinical Data in Orphan Skin Disease Bullous Pemphigoid
8:40am
6-K
3oh7t9hmdtxa1bbr8t
29 Mar 19
Akari Therapeutics to Provide Update on its Eye Disease Program During Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
4:42pm
6-K
jn4z4 coo5
13 Mar 19
Positive FDA Meeting Outlines Path Ahead for Akari Therapeutics’s Coversin
9:04am